 We think that Stryker Corp. stock currently is a better pick compared to its industry peer, Medtronic stock, despite it being the more expensive of the two, trading at 5.7x trailing revenues compared to 4.7x for Medtronic. Even if we were to look at the PEBIT ratio, SYK stock appears to be more. 